SSY Group warns of profit decline amid turnover drop

SSY Group Limited (HKEX:2005) has issued a profit warning, projecting a 45% to 60% decrease in profit attributable to equity shareholders for the six months ending June 30, 2025, compared to HK$685,737,000 in the same period last year. This anticipated decline is primarily attributed to a drop in unaudited turnover. The company's unaudited operating results for the three months ended March 31, 2025, showed a 36.9% decrease in turnover to approximately HK$1,136 million, compared to HK$1,799 million in the same period of 2024, largely due to reduced sales of intravenous infusion solutions and ampoule injections. Gross profit also fell by 50.6% to approximately HK$509 million. Contributing factors to this downturn include reduced demand post-influenza outbreak in PRC, volume-based procurement pressures, and decreased sales of Bromhexine Hydrochloride ampoule injections. The company advises shareholders and potential investors to exercise caution when dealing in the securities of the company.